Mol. Cells 2010; 30(5): 383-391
Published online November 18, 2010
https://doi.org/10.1007/s10059-010-0157-1
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: samar.basu@pubcare.uu.se
Oxidative stress and inflammation are supposed to be the key players of several acute and chronic diseases, and also for progressive aging process. Eicosanoids, especially prostaglandin F2α (PGF2α) and F2-isoprostanes are endogenous compounds that are involved both in physiology and the above mentioned pathologies. These compounds are biosynthesized mainly from esterified arachidonic acid through both enzymatic and non-enzymatic free radical-catalysed reactions in vivo, respectively. They have shown to possess potent biological activities in addition to their application as biomarkers of oxidative stress and inflammation. Recent advancement of methodologies has made it possible to quantify these compounds more reliably and apply them in various in vivo studies successfully. Today, experimental and clinical studies have revealed that both PGF2α and F2-isoprostanes are involved in severe acute or chronic inflammatory conditions such as rheumatic diseases, asthma, risk factors of atherosclerosis, diabetes, ischemia-reperfusion, septic shock and many others. These evidences promote that assessment of bioactive PGF2α and F2-isoprostanes simultaneously in body fluids offers unique non-invasive analytical opportunity to study the function of these eicosanoids in physiology, oxidative stress-related and inflammatory diseases, and also in the determination of potency of various radical scavengers, anti-inflammatory compounds, drugs, antioxidants and diet.
Keywords eicosanoids, inflammation, isoprostanes, oxidative stress, prostaglandins
Mol. Cells 2010; 30(5): 383-391
Published online November 30, 2010 https://doi.org/10.1007/s10059-010-0157-1
Copyright © The Korean Society for Molecular and Cellular Biology.
Samar Basu*
Oxidative Stress and Inflammation, Department of Public Health and Caring Sciences, Faculty of Medicine, Uppsala University, Uppsala, Sweden, and Centre of Excellence-Inflammation, Uppsala University Hospital, Uppsala, Sweden
Correspondence to:*Correspondence: samar.basu@pubcare.uu.se
Oxidative stress and inflammation are supposed to be the key players of several acute and chronic diseases, and also for progressive aging process. Eicosanoids, especially prostaglandin F2α (PGF2α) and F2-isoprostanes are endogenous compounds that are involved both in physiology and the above mentioned pathologies. These compounds are biosynthesized mainly from esterified arachidonic acid through both enzymatic and non-enzymatic free radical-catalysed reactions in vivo, respectively. They have shown to possess potent biological activities in addition to their application as biomarkers of oxidative stress and inflammation. Recent advancement of methodologies has made it possible to quantify these compounds more reliably and apply them in various in vivo studies successfully. Today, experimental and clinical studies have revealed that both PGF2α and F2-isoprostanes are involved in severe acute or chronic inflammatory conditions such as rheumatic diseases, asthma, risk factors of atherosclerosis, diabetes, ischemia-reperfusion, septic shock and many others. These evidences promote that assessment of bioactive PGF2α and F2-isoprostanes simultaneously in body fluids offers unique non-invasive analytical opportunity to study the function of these eicosanoids in physiology, oxidative stress-related and inflammatory diseases, and also in the determination of potency of various radical scavengers, anti-inflammatory compounds, drugs, antioxidants and diet.
Keywords: eicosanoids, inflammation, isoprostanes, oxidative stress, prostaglandins
Chuntao Yang, Hongzhong Ling, Meifen Zhang, Zhanli Yang, Xiuyu Wang, Fanqin Zeng, Chuhuai Wang, and Jianqiang Feng*
Mol. Cells 2011; 31(6): 531-538 https://doi.org/10.1007/s10059-011-1025-3Yoonjeong Lee, Jaehyeon Kim, Hyunjin Kim, Ji Eun Han, Sohee Kim, Kyong-hwa Kang, Donghoon Kim, Jong-Min Kim, and Hyongjong Koh
Mol. Cells 2022; 45(7): 454-464 https://doi.org/10.14348/molcells.2022.5002Jihyun Kim, Seungwon Ryu, and Hye Young Kim
Mol. Cells 2021; 44(5): 301-309 https://doi.org/10.14348/molcells.2021.0053